Cognitive-Somatosensory-Motor Training for Stroke
(iCOSMO Trial)
Trial Summary
What is the purpose of this trial?
The iCOSMO study investigates the feasibility and beneficial effects of an intervention combining sensation, motor and cognition to improve arm and hand function after chronic stroke.
Do I have to stop taking my current medications for the trial?
The trial protocol does not specify whether you need to stop taking your current medications.
What data supports the idea that Cognitive-Somatosensory-Motor Training for Stroke is an effective treatment?
The available research shows that Cognitive-Somatosensory-Motor Training can improve motor function in stroke patients. For example, one study found that somatosensory stimulation, which is part of this training, led to better hand motor function in patients with chronic strokes. This improvement was greater than in sessions without this stimulation, and the benefits lasted for at least 30 days. This suggests that the treatment can be a helpful tool in stroke rehabilitation, especially for those with certain types of brain injuries.12345
What safety data exists for Cognitive-Somatosensory-Motor Training for stroke?
The provided research does not directly address safety data for Cognitive-Somatosensory-Motor Training or its variants like iCOSMO. The studies focus on the effectiveness of somatosensory retraining and stimulation in improving motor function after stroke, but they do not specifically mention safety outcomes or adverse effects related to these interventions.13467
Is the treatment Cognitive-Somatosensory-Motor Training for Stroke promising?
Yes, Cognitive-Somatosensory-Motor Training for Stroke is promising because it combines physical and sensory training to improve motor and sensory functions in stroke patients. Studies show that somatosensory stimulation can enhance motor function and help maintain training benefits, making it a valuable tool for stroke rehabilitation.23468
Research Team
Mark Bayley, MD
Principal Investigator
Toronto Rehabilitation Institute
Eligibility Criteria
The iCOSMO trial is for individuals who have had a stroke and are looking to improve the function of their arm and hand. Specific eligibility criteria details were not provided.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Baseline
Participants are tested at the start and end of the baseline phase
Treatment
Participants receive the iCOSMO intervention or a home-based exercise programme for 6 weeks
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- integrated Somatosensory-MOtor training using a COgnitive approach(iCOSMO) (Behavioural Intervention)
Find a Clinic Near You
Who Is Running the Clinical Trial?
University Health Network, Toronto
Lead Sponsor
Dr. Brad Wouters
University Health Network, Toronto
Chief Medical Officer since 2020
MD from University of Toronto
Dr. Kevin Smith
University Health Network, Toronto
Chief Executive Officer since 2018
Professor at McMaster University and University of Toronto
StrokeCog clinical training platform
Collaborator